Roth Capital Starts Neurocrine Bio. (NBIX) at Buy
Get Alerts NBIX Hot Sheet
Price: $137.92 +0.07%
Rating Summary:
24 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
24 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Roth Capital initiates coverage on Neurocrine Bio. (NASDAQ: NBIX) with a Buy. PT $14.00.
For an analyst ratings summary and ratings history on Neurocrine Bio. click here. For more ratings news on Neurocrine Bio. click here.
Shares of Neurocrine Bio. closed at $7.38 yesterday.
For an analyst ratings summary and ratings history on Neurocrine Bio. click here. For more ratings news on Neurocrine Bio. click here.
Shares of Neurocrine Bio. closed at $7.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Neurocrine Biosciences (NBIX) Initiates Phase 1 Study of NBI-1065890
- RBC Capital Starts TruBridge Inc (TBRG) at Outperform
- Truist Securities Starts Merus N.V. (MRUS) at Buy, 'there is more upside on Peto's 2 clinical catalysts'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!